Articles tagged with: Genetic Testing
News»

Myeloma researchers and physicians gathered at the 2011 International Myeloma Workshop (IMW) earlier this month to discuss the current understanding of the biology and treatment of multiple myeloma.
Highlights from each day of the workshop were covered in the Beacon’s daily updates from the meeting.
Now that the IMW has ended, however, and there has been some time to digest all that happened, it seems like a good time to ask: What were the key themes and learnings from the conference?
To answer this question, The Beacon went back and reviewed its coverage of the IMW, and …
News»

The third day of the American Society of Clinical Oncology (ASCO) 2010 annual meeting in Chicago was tailor-made for morning people interested in multiple myeloma. The key myeloma-related activity on Sunday, June 6 was a morning abstract session starting at 9:30 a.m. Nine abstracts were presented and discussed over the course of three hours.
The first two presentations dealt with Velcade (bortezomib)-related research.
Dr. Antonio Palumbo of the University of Turin presented the results of the first study. It compared two regimens for the treatment of newly diagnosed elderly myeloma patients. The first regimen involved …
News»
Tests for genetic material circulating in the bloodstream could soon help predict, diagnose, and monitor a multitude of different disorders, including multiple myeloma. The science remains in the research stages, but the technology appears promising and companies have begun investments into commercial applications.
DNA – our genetic “blueprint” – resides within the body’s cells, not only dictating our fetal development in the womb but also choreographing our cellular functioning throughout life. Scientists have discovered, however, that snippets of DNA and its genetic sister, RNA, also freely float throughout our …